Evidence shows that the central nervous system monitors and modulates the activity of both circulating and tissue immune cells via the neuroendocrine system and autonomic nerves.
Furthermore, findings over the last decade have demonstrated that the vagus nerve represents an important bi-directional link between the brain and immune system.
Afferent vagal pathways transmit information to the brain related to peripheral inflammation so as to participate in the activation of adaptive reactions, including fever and sickness behavior. On the other side, efferent vagal pathways inhibit the synthesis and release of pro-inflammatory cytokines by peripheral immune cells. Because activation of afferent vagal pathways by immune stimuli leads to suppression of immune reactions, the term inflammatory reflex was introduced. The inflammatory reflex adjusts the intensity and duration of inflammatory reactions according to actual needs, thus protecting an organism from tissue damage induced by excessive inflammation. Both experimental and clinical studies suggest that inappropriate activation of the inflammatory reflex participates in the development of diseases characterized by excessive production of cytokines.', '
Regulation of immune system activity by the central nervous system plays an important role in both physiological and pathological conditions. This is shown by several studies demonstrating that the vagus nerve represents one of the key brain structures participating in monitoring immune system activity. The vagus nerve is involved in the transmission of information from inflamed peripheral tissues to the brain, and participates in both homeostatic and behavioral adaptation reactions, including the induction of fever and sickness behavior. Vagal afferent pathways are activated by immune stimuli either directly or indirectly via vagal paraganglia cells. These paraganglia cells possess receptors for immune signaling molecules (e.g. IL-1) and transmit signals from immune cells to the afferent vagal pathways. The importance of afferent vagal pathways in the transmission of immune-related signals is demonstrated by the inhibitory effect of subdiaphragmatic vagotomy on the development of fever responses induced by intraperitoneal injection of low doses of IL-1beta [1,2].
Although the role of afferent vagal pathways in the transmission of immune signals to the brain has been demonstrated over time, the role of efferent vagal pathways in the modulation of immune cells activity has only recently been shown. This occurred during the search for a new compound for the treatment of excessive inflammatory reactions (e.g. sepsis) with the synthesis of CNI-1493 (tetravalent guanyl-hydrazone). This compound was shown to inhibit the release of pro-inflammatory cytokines from macrophages, significantly prolonging the survival of animals in experimental models of sepsis induced by endotoxin . Moreover, it was found that application of CNI-1493 increased the activity of efferent vagal pathways and that its anti-inflammatory effects were blocked by vagotomy . Later studies demonstrated that CNI-1493 inhibits both the synthesis and release of pro-inflammatory cytokines from immune cells through activation of efferent vagal pathways at the level of central nervous system. Later, this inhibitory effect of the vagus nerve on immune cells activity was found to be mediated by acetylcholine, and the term cholinergic anti-inflammatory pathway was introduced [5,6].
Inflammatory reflex and cholinergic anti-inflammatory pathway
The synthesis and release of cytokines represents one of the most basic activities during immune reactions. However, inappropriate cytokine synthesis may stimulate excessive inflammatory reactions causing damage to peripheral tissues and organs. It is therefore not surprising that organisms have several mechanisms regulating the intensity of inflammation, including the inflammatory reflex of the vagus nerve.
The pathways of the vagus nerve that participate in the monitoring and modulation of immune reactions in the periphery of an organism make up the sensory arm of the inflammatory reflex. This “arm” consists of afferent vagal pathways transmitting signals to the brain generated in inflammation-affected tissues. The motor arm of this reflex consists of the efferent vagal pathways that constitute the cholinergic anti-inflammatory pathway (Fig. 1).
As a result of activating the motor arm, acetylcholine released from vagal nerve endings potently inhibits the production of cytokines by macrophages, thus protecting peripheral tissues from inflammatory injury . As a result of these observations, it was concluded that the inflammatory reflex represents a crucial neural mechanism controlling the synthesis and release of cytokines [5,6].
Either pharmacological or electrical stimulation of efferent vagal pathways significantly inhibits the release of TNF-alpha in animals given a lethal dose of endotoxin. Furthermore, studies have shown that stimulation of the efferent pathways of the vagus nerve has beneficial effects such as inhibiting the development of pathological consequences in animal models of ischemia-reperfusion injury, myocardial ischemia, hemorrhagic shock, shock induced by occlusion of splanchnic artery, ileus, experimental arthritis, pancreatitis, and burn-induced organ dysfunction [8-12].
The inhibition of cytokine biosynthesis by the cholinergic anti-inflammatory pathway is caused by cholinergic neurotransmission acting on alpha7 subtype acetylcholine receptors (alpha7nAChR) located on macrophages and other cytokine synthesizing cells [13,14]. As evidence of this, both direct electrical stimulation of the vagus nerve and the application of alpha7nAChR agonists inhibit synthesis of TNF-alpha, IL-1beta, IL-6, IL-8, and HMGB1. This binding of acetylcholine and acetylcholine analogues to the alpha7nAChR of immune cells also induces a reduction in the nuclear translocation of NF-kappaB, a pro-inflammatory gene regulatory protein. Furthermore, as other immune cells, including lymphocytes and microglia express alpha7nAChR, this suggests that the cholinergic anti-inflammatory pathway may have wide effects across various immune cells . This assumption is supported by the finding of increased proliferation and cytokine secretion by CD4+ T cells in mice that have undergone subdiaphragmatic vagotomy. Furthermore, administration of nicotine restored the reactivity of immune cells in these animals, while administration of nicotine receptor antagonists induced an effect similar to subdiaphragmatic vagotomy. These findings suggest that efferent vagal pathways modulate a tonic inhibition of macrophage and T cell activity. Regardless of the whatever else is learned about this system, it can be agreed that the involvement of the vagus nerve in regulation of immune function is highly complex .
The role of the spleen
The spleen plays a key role in the regulation of immune function by the vagus nerve. During their passage through the spleen, circulating immune cells are exposed to vagus nerve endings . Moreover, as the spleen is a prominent source of circulating TNF-alpha during endotoxemia and stimulation of the vagus nerve inhibits endotoxin-induced increases in plasma TNF-alpha, it is possible that lymphoid compartments of the spleen represent a target for vagal anti-inflammatory action . However, the role of direct vagal fibers innervating the spleen in the regulation of inflammation remains questionable. In fact, anatomical and physiological studies indicate that the vagus nerve modulates the activity of immune cells within the spleen indirectly via activation of sympathetic postganglionic neurons localized in the coeliac ganglia. It is therefore possible that the vagus nerve modulates immune system activity in the spleen indirectly through regulation of norepinephrine release from sympathetic nerve endings .
The importance of cholinergic anti-inflammatory pathway in human medicine
The majority of data related to anti-inflammatory effects of the vagus nerve have been obtained in animal studies. However, several clinical studies on the role of cholinergic anti-inflammatory pathway in humans were published recently. In one study administration of nicotine before activation of the immune system by lipopolysaccharide attenuated increases in body temperature and increased plasma IL-10 and corticosterone levels .
Anti-inflammatory effect of the vagus nerve may explain several clinical findings. For example, increased plasma levels of C reactive protein, IL-6, and TNF-alpha were found in patients with insulin resistance, diabetes mellitus type 2, hypertension, hyperlipidemia, metabolic syndrome, and Alzheimer’s disease; all conditions characterized by low-grade inflammation. Interestingly, increased plasma and tissue activity of butyrylcholinesterase and acetylcholinesterase were found in these patients. Since increased activation of these enzymes leads to decreased transmission of cholinergic signals and acetylcholine represents a key molecule in the cholinergic anti-inflammatory pathway, increased degradation of acetylcholine may participate in exaggerated inflammatory reactions . Moreover, the beneficial effects of nicotine treatment in patients with ulcerative colitis suggests that inappropriate activity of cholinergic anti-inflammatory pathway may participate in its development as well .
Several methods can be used to stimulate the cholinergic anti-inflammatory pathway. For example, it is possible to activate the afferent and/or efferent arm of inflammatory reflex by stimulating the cholinergic anti-inflammatory pathway at the central level by administration of muscarine receptor agonists, ACTH, ghrelin, or centrally acting acetylcholinesterase inhibitors [5,21,22]. Ingestion of polyunsaturated fatty acids also increases vagal anti-inflammatory activity  and therefore may represent a potent and simple therapeutic method for the treatment of inflammatory diseases. Moreover, decreased pro-inflammatory immune cell responses were found in patients with epilepsy treated by electrical stimulation of the vagus nerve .
Based on published data it is suggested that activation of cholinergic anti-inflammatory pathway may represent a useful therapeutic approach. However, exaggerated activation of the cholinergic anti-inflammatory pathway may excessively suppress immune function, thereby inducing unfavorable consequences . Therefore, it is necessary to consider two consequences of activating the cholinergic-anti-inflammatory pathway: 1) inhibition of inflammation that has beneficial effects during septic or hemorrhagic shock, ischemia-reperfusion injury, and other situations related to excessive stimulation of immune functions; 2) inhibition of immune functions may negatively influence defense mechanisms against invading pathogens, such as during the early stages of bacterial pancreatitis. Furthermore, the consequences of activating the cholinergic anti-inflammatory pathway may depend on not only the pathological situation, but the stage of disease as well. This is seen during the early stages of inflammatory reaction where induced activation of the cholinergic anti-inflammatory pathway will produce negative effects; while in later stages it may be beneficial, protecting organisms from injury induced by excessive inflammatory reaction.
Animal studies have unambiguously shown that the vagus nerve plays an important role in the regulation of immune reactions in various animal models of inflammatory diseases. While several studies in humans also indicate the importance of the vagus nerve in the regulation of immune function, it is necessary to take into consideration the fact that these studies used mainly ex vivo approaches, using heart rate variability as a marker of cholinergic anti-inflammatory pathway activity. Therefore, further experimental and clinical studies will be necessary to elucidate the role of the vagus nerve in the modulation of inflammatory reactions in humans.
This work was supported by the Slovak Research and Development Agency under the contract No. APVV-0045-06, VEGA grants (1/0258/10, 1/0260/10, 2/0010/09) and European Regional Development Fund Research and Development Grant No. NFP26240120024.
Nonstandard Abbreviations: alpha7nAChR, alpha7 subtype acetylcholine receptors; HMGB1, high-mobility group box 1; IL, interleukin; LPS, lipopolysaccharide; TNF-alpha, tumor necrosis factor alpha
K Ondicova - Institute of Pathophysiology, Faculty of Medicine, Comenius University, 811 08 Bratislava
B Mravec - Institute of Experimental Endocrinology, Slovak Academy of Sciences, 833 06 Bratislava, Slovak Republic
- Watkins LR, Maier SF, Goehler LE: Cytokine-to-brain communication: a review & analysis of alternative mechanisms. Life Sci, 1995; 57: 1011-26
- Hansen MK, O''Connor KA, Goehler LE, Watkins LR, Maier SF: The contribution of the vagus nerve in interleukin-1beta-induced fever is dependent on dose. Am J Physiol Regul Integr Comp Physiol, 2001; 280: R929-34
- Bianchi M, Ulrich P, Bloom O et al: An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality. Mol Med, 1995; 1: 254-66
- Borovikova LV, Ivanova S, Nardi D et al: Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation. Auton Neurosci, 2000; 85: 141-7
- Andersson J: The inflammatory reflex--introduction. J Intern Med, 2005; 257: 122-5
- Tracey KJ: The inflammatory reflex. Nature, 2002; 420: 853-9
- Johnston GR, Webster NR: Cytokines and the immunomodulatory function of the vagus nerve. Br J Anaesth, 2009; 102: 453-62
- Sadis C, Teske G, Stokman G et al: Nicotine protects kidney from renal ischemia/reperfusion injury through the cholinergic anti-inflammatory pathway. PLoS ONE, 2007; 2: e469
- Niederbichler AD, Papst S, Claassen L et al: Burn-Induced Organ Dysfunction: Vagus Nerve Stimulation Improves Cardiac Function. Eplasty, 2010; 10: e45
- Altavilla D, Guarini S, Bitto A et al: Activation of the cholinergic anti-inflammatory pathway reduces NF-kappab activation, blunts TNF-alpha production, and protects againts splanchic artery occlusion shock. Shock, 2006; 25: 500-6
- Giebelen IA, van Westerloo DJ, LaRosa GJ, de Vos AF, van der Poll T: Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung. Shock, 2007; 28: 700-3
- Tracey KJ: Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest, 2007; 117: 289-96
- Gallowitsch-Puerta M, Tracey KJ: Immunologic role of the cholinergic anti-inflammatory pathway and the nicotinic acetylcholine alpha 7 receptor. Ann N Y Acad Sci, 2005; 1062: 209-19
- Gallowitsch-Puerta M, Pavlov VA: Neuro-immune interactions via the cholinergic anti-inflammatory pathway. Life Sci, 2007; 80: 2325-9
- Karimi K, Bienenstock J, Wang L, Forsythe P: The vagus nerve modulates CD4(+) T cell activity. Brain Behav Immun, 2009:
- Tracey KJ: Understanding immunity requires more than immunology. Nat Immunol, 2010; 11: 561-4
- Huston JM, Ochani M, Rosas-Ballina M et al: Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med, 2006; 203: 1623-8
- Rosas-Ballina M, Tracey KJ: Cholinergic control of inflammation. J Intern Med, 2009; 265: 663-79
- Wittebole X, Hahm S, Coyle SM, Kumar A, Calvano SE, Lowry SF: Nicotine exposure alters in vivo human responses to endotoxin. Clin Exp Immunol, 2007; 147: 28-34
- Das UN: Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammation. Med Sci Monit, 2007; 13: RA214-21
- Wu R, Dong W, Ji Y et al: Orexigenic hormone ghrelin attenuates local and remote organ injury after intestinal ischemia-reperfusion. PLoS ONE, 2008; 3: e2026
- Pavlov VA, Parrish WR, Rosas-Ballina M et al: Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Brain Behav Immun, 2009; 23: 41-5
- Luyer MD, Greve JW, Hadfoune M, Jacobs JA, Dejong CH, Buurman WA: Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve. J Exp Med, 2005; 202: 1023-9
- De Herdt V, Bogaert S, Bracke KR et al: Effects of vagus nerve stimulation on pro- and anti-inflammatory cytokine induction in patients with refractory epilepsy. J Neuroimmunol, 2009; 214: 104-8
- Kox M, Hoedemaekers AW, Pickkers P, van der Hoeven JG, Pompe JC: A possible role for the cholinergic anti-inflammatory pathway in increased mortality observed in critically ill patients receiving nicotine replacement therapy. Crit Care Med, 2007; 35: 2468-9; author reply 9